JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Scope & Guideline
Innovative insights into digestive and liver health.
Introduction
Aims and Scopes
- Gastrointestinal Disorders and Diseases:
Research includes studies on various gastrointestinal disorders such as inflammatory bowel disease (IBD), functional gastrointestinal disorders, and colorectal cancer, with a focus on their pathophysiology, diagnosis, and treatment. - Liver Diseases and Hepatology:
The journal publishes extensive research on liver diseases, including hepatitis B and C, liver cirrhosis, hepatocellular carcinoma, and metabolic-associated fatty liver disease, emphasizing disease mechanisms, clinical management, and therapeutic advancements. - Endoscopic Techniques and Innovations:
A significant focus is placed on the development and evaluation of endoscopic techniques, including endoscopic submucosal dissection, capsule endoscopy, and advanced imaging modalities, aimed at improving diagnostic and therapeutic outcomes. - Microbiome and Metabolism:
Research on the gut microbiome's role in gastrointestinal and liver diseases is prevalent, particularly studies exploring microbiota composition, metabolic pathways, and their implications for disease management and treatment efficacy. - Clinical Trials and Therapeutic Interventions:
The journal features clinical trial results and studies evaluating new therapeutic agents, including biologics and novel pharmacological treatments, highlighting their effectiveness and safety in managing gastrointestinal and liver conditions. - Public Health and Epidemiology:
Contributions addressing the epidemiological aspects of gastrointestinal and liver diseases, including prevalence studies, risk factors, and public health interventions, are integral to the journal's scope.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on metabolic dysfunction-associated fatty liver disease has gained prominence, with studies exploring its pathogenesis, management strategies, and implications for patient outcomes. - Artificial Intelligence in Gastroenterology:
The integration of artificial intelligence and machine learning technologies in diagnostic processes and treatment planning has become a significant focus, enhancing the accuracy and efficiency of clinical practices. - Gut Microbiome Research:
There is an increasing emphasis on understanding the role of the gut microbiome in gastrointestinal and liver diseases, with studies investigating its impact on disease progression and treatment responses. - Personalized Medicine Approaches:
Personalized and precision medicine approaches in treating inflammatory bowel disease and hepatological conditions are emerging as a key area, reflecting a shift towards individualized patient care based on genetic and phenotypic markers. - Telehealth and Virtual Care Models:
The COVID-19 pandemic has accelerated the adoption of telehealth and virtual care models, with ongoing research evaluating their effectiveness in managing gastrointestinal diseases and improving patient access to care. - Patient-Reported Outcomes and Quality of Life:
An increasing number of studies are focusing on patient-reported outcomes and health-related quality of life, particularly in chronic conditions like IBD and liver diseases, emphasizing the importance of patient perspectives in treatment evaluation.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable reduction in studies focusing solely on traditional pharmacological treatments for gastrointestinal and liver diseases, as interest shifts towards novel therapies and precision medicine. - Surgical Techniques in Gastroenterology:
Research pertaining to conventional surgical techniques has waned, with a growing preference for minimally invasive endoscopic procedures and innovative technologies for treatment. - Epidemiological Studies of Common Conditions:
While public health remains important, there is a decline in the volume of epidemiological studies focusing solely on common gastrointestinal conditions, as researchers increasingly target specific populations or emerging diseases. - General Reviews of Established Guidelines:
The publication of general reviews summarizing established clinical guidelines has decreased, as the focus has shifted towards innovative practices and real-world applications of new treatments.
Similar Journals
ACTA GASTRO-ENTEROLOGICA BELGICA
Fostering Collaboration in Gastroenterology ExcellenceACTA GASTRO-ENTEROLOGICA BELGICA is a prestigious journal dedicated to advancing the field of gastroenterology through the dissemination of high-quality research and clinical insights. Published by UNIVERSITE CATHOLIQUE DE LOUVAIN (UCL), this journal is an essential resource for researchers, healthcare professionals, and students alike, focusing on a wide range of topics including gastrointestinal diseases, treatments, and innovations in clinical practices. While the journal operates under a traditional access model, its impact in the academic community is significant, ensuring that vital research is communicated effectively to stakeholders in Belgium and beyond. With its commitment to academic excellence, ACTA GASTRO-ENTEROLOGICA BELGICA plays a crucial role in fostering high-level discourse and collaboration among experts in the field, ultimately encouraging advancements that improve patient care and outcomes.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Exploring innovative solutions in gastroenterology.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Unlocking New Frontiers in Digestive Health ResearchSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.
BMJ Open Gastroenterology
Empowering Global Insights in Gastrointestinal MedicineBMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.
Korean Journal of Gastroenterology
Pioneering Research for Better Gastrointestinal CareKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
WORLD JOURNAL OF GASTROENTEROLOGY
Transforming knowledge into practice in gastroenterology.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
Gastroenterology Research and Practice
Bridging Research and Practice in GastroenterologyGastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.
DIGESTIVE AND LIVER DISEASE
Pioneering insights for a healthier tomorrow.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Gastrointestinal Disorders
Exploring the Frontiers of GI Disorders and TreatmentsGastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.
Translational Gastroenterology and Hepatology
Bridging Discovery and Care in Gastroenterology.Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.